Physician profile
Peter Lasater
NPI 1356755433
$33,374.17
in general payments reported to CMS, 2019-2025
21 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $6,045 · 2021: $37.15 · 2022: $3,777 · 2023: $85.19 · 2024: $85.62 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $22,320.12 | 2019-2020 | |
| Djo, LLC | $5,833.35 | 2019-2020 | |
| Pinnacle, INC | $4,363.46 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $204.37 | 2019-2025 | Juggerknotless Soft Anchor |
| Wright Medical Technology, INC. | $100.05 | 2019-2020 | |
| Vericel Corporation | $90.21 | 2021-2024 | Maci |
| Medtronic USA, INC. | $84.12 | 2019 | |
| Convatec INC. | $50.94 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $43.88 | 2022-2024 | Euflexxa |
| Sanofi-Aventis U.S. LLC | $40.37 | 2022-2023 | |
| Curonix LLC | $36.82 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $28.16 | 2025 | Senza |
| Alvogen INC | $27.74 | 2022 | |
| Bioventus LLC | $26.34 | 2022 | |
| Polynovo North America LLC | $23.44 | 2025 | Novosorb Btm |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $19.07 | 2023 | Tremfya |
| Boston Scientific Corporation | $18.58 | 2021 | |
| Alexion Pharmaceuticals, INC. | $17.99 | 2022 | |
| Radius Health, INC. | $15.54 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.50 | 2022 | |
| Amgen INC. | $14.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lasater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.